Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway

Zhengming Li1,*, Pijian Yang2,*, Yuzhen Liang1,*, Ning Xia2,*, Yingrong Li1, Hongye Su1, Hailin Pan1 1Department of Endocrinology and Metabolism, Second Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China; 2Department of Endocrinology and Metabolism, The...

Full description

Bibliographic Details
Main Authors: Li Z, Yang P, Liang Y, Xia N, Li Y, Su H, Pan H
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
Online Access:https://www.dovepress.com/effects-of-liraglutide-on-lipolysis-and-the-ac3pkahsl-pathway-peer-reviewed-article-DMSO
id doaj-ea800619b7954806bd9de5ccd9934180
record_format Article
spelling doaj-ea800619b7954806bd9de5ccd99341802020-11-25T01:46:44ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity : Targets and Therapy1178-70072019-09-01Volume 121697170348353Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathwayLi ZYang PLiang YXia NLi YSu HPan HZhengming Li1,*, Pijian Yang2,*, Yuzhen Liang1,*, Ning Xia2,*, Yingrong Li1, Hongye Su1, Hailin Pan1 1Department of Endocrinology and Metabolism, Second Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China; 2Department of Endocrinology and Metabolism, The First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yuzhen LiangDepartment of Endocrinology and Metabolism, Second Affiliated Hospital of Guangxi Medical University, Nanning 530007, People’s Republic of ChinaEmail liangyuzhen26@163.comNing XiaDepartment of Endocrinology and Metabolism, The First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning 530021, People’s Republic of ChinaEmail xianinggxmu@163.comBackground: Liraglutide reduces blood glucose, body weight and blood lipid levels. Hormone-sensitive lipase (HSL) is a key enzyme in lipolysis. Evidence from our and other studies have demonstrated that adenylate cyclase 3 (AC3) is associated with obesity and can be upregulated by liraglutide in obese mice. In the present study, we investigated whether hepatic HSL activity is regulated by liraglutide and characterized the effect of liraglutide in the AC3/protein kinase A (PKA)/HSL signalling pathway.Methods: Obese mice or their lean littermates were treated with liraglutide or saline for 8 weeks. Serum was collected for the measurement of insulin and lipids. We investigated hepatic AC3, HSL and phosphorylated HSL Ser-660 (p-HSL(S660)) protein expression levels andAC3 and HSL mRNA expression levels and cyclic adenosine monophosphate (cAMP), PKA activity in liver tissue.Results: Liraglutide treatment decreased triglycerides (TGs) and free fatty acids (FFAs), increased glycerol, and upregulated hepatic AC3 and p-HSL(s660) levels and cAMP and PKA activities.Conclusion: The results suggest that liraglutide can upregulates AC3/PKA/HSL pathway and may promotes lipolysis.Keywords: liraglutide, obesity, lipolysis, adenylate cyclase 3, hormone-sensitive lipasehttps://www.dovepress.com/effects-of-liraglutide-on-lipolysis-and-the-ac3pkahsl-pathway-peer-reviewed-article-DMSOliraglutideobesitylipolysisadenylate cyclase 3hormone-sensitive lipase
collection DOAJ
language English
format Article
sources DOAJ
author Li Z
Yang P
Liang Y
Xia N
Li Y
Su H
Pan H
spellingShingle Li Z
Yang P
Liang Y
Xia N
Li Y
Su H
Pan H
Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
liraglutide
obesity
lipolysis
adenylate cyclase 3
hormone-sensitive lipase
author_facet Li Z
Yang P
Liang Y
Xia N
Li Y
Su H
Pan H
author_sort Li Z
title Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway
title_short Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway
title_full Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway
title_fullStr Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway
title_full_unstemmed Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway
title_sort effects of liraglutide on lipolysis and the ac3/pka/hsl pathway
publisher Dove Medical Press
series Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
issn 1178-7007
publishDate 2019-09-01
description Zhengming Li1,*, Pijian Yang2,*, Yuzhen Liang1,*, Ning Xia2,*, Yingrong Li1, Hongye Su1, Hailin Pan1 1Department of Endocrinology and Metabolism, Second Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of China; 2Department of Endocrinology and Metabolism, The First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yuzhen LiangDepartment of Endocrinology and Metabolism, Second Affiliated Hospital of Guangxi Medical University, Nanning 530007, People’s Republic of ChinaEmail liangyuzhen26@163.comNing XiaDepartment of Endocrinology and Metabolism, The First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning 530021, People’s Republic of ChinaEmail xianinggxmu@163.comBackground: Liraglutide reduces blood glucose, body weight and blood lipid levels. Hormone-sensitive lipase (HSL) is a key enzyme in lipolysis. Evidence from our and other studies have demonstrated that adenylate cyclase 3 (AC3) is associated with obesity and can be upregulated by liraglutide in obese mice. In the present study, we investigated whether hepatic HSL activity is regulated by liraglutide and characterized the effect of liraglutide in the AC3/protein kinase A (PKA)/HSL signalling pathway.Methods: Obese mice or their lean littermates were treated with liraglutide or saline for 8 weeks. Serum was collected for the measurement of insulin and lipids. We investigated hepatic AC3, HSL and phosphorylated HSL Ser-660 (p-HSL(S660)) protein expression levels andAC3 and HSL mRNA expression levels and cyclic adenosine monophosphate (cAMP), PKA activity in liver tissue.Results: Liraglutide treatment decreased triglycerides (TGs) and free fatty acids (FFAs), increased glycerol, and upregulated hepatic AC3 and p-HSL(s660) levels and cAMP and PKA activities.Conclusion: The results suggest that liraglutide can upregulates AC3/PKA/HSL pathway and may promotes lipolysis.Keywords: liraglutide, obesity, lipolysis, adenylate cyclase 3, hormone-sensitive lipase
topic liraglutide
obesity
lipolysis
adenylate cyclase 3
hormone-sensitive lipase
url https://www.dovepress.com/effects-of-liraglutide-on-lipolysis-and-the-ac3pkahsl-pathway-peer-reviewed-article-DMSO
work_keys_str_mv AT liz effectsofliraglutideonlipolysisandtheac3pkahslpathway
AT yangp effectsofliraglutideonlipolysisandtheac3pkahslpathway
AT liangy effectsofliraglutideonlipolysisandtheac3pkahslpathway
AT xian effectsofliraglutideonlipolysisandtheac3pkahslpathway
AT liy effectsofliraglutideonlipolysisandtheac3pkahslpathway
AT suh effectsofliraglutideonlipolysisandtheac3pkahslpathway
AT panh effectsofliraglutideonlipolysisandtheac3pkahslpathway
_version_ 1725017450411458560